Skip to main content

Table 1 Enrolled non-RA CTD patients and the prevalence of the anti-CCP antibody

From: Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency

Disease

n

Anti-CCP-positive, n (%)

SLE

318

16 (5.0)

Primary SS

183

7 (3.8)

SSc

97

2 (2.1)

PM/DM

54

3 (5.6)

MCTD/overlap syndrome

60

3 (5)

AOSD

28

1 (3.6)

SpA

38∗

1 (2.6)

Others†

4

0 (0)

Total

780‡

33 (4.2)

  1. CTD connective tissue disease,; systemic lupus erythematosus, SS Sjögren’s syndrome, SSc systemic sclerosis, PM polymyositis, DM dermatomyositis, MCTD mixed connective tissue disease, AOSD adult-onset Still’s disease, SpA spondyloarthritis
  2. †Takayasu arteritis; n = 1, anti-phospholipid syndrome; n = 1, polymyalgia rheumatica; n = 1, polyarteritis nodosa; n = 1
  3. ‡Including overlap
  4. *Thirteen out of 38 patients had erosive peripheral arthritis